Antimalarial Virtual Screening Pipeline Results
==================================================

Run Date: 2025-05-31 22:33:14

library_size: 212670
reference_size: 400
total_molecules: 212670
drug_like_molecules: 196330
pass_rate: 92.31673484741619
lipinski_pass_rate: 93.79837306625288
avg_lipinski_violations: 0.32313913575022335
additional_pass_rate: 97.94940518173696
violation_analysis:
  lipinski: {'MW': {'violation_count': np.int64(17604), 'violation_rate': np.float64(8.277613203554804), 'mean_value': np.float64(371.7383211576771), 'criteria': '0 <= MW <= 500'}, 'LogP': {'violation_count': np.int64(50194), 'violation_rate': np.float64(23.60182442281469), 'mean_value': np.float64(3.917191542577705), 'criteria': '-5 <= LogP <= 5'}, 'HBA': {'violation_count': np.int64(883), 'violation_rate': np.float64(0.41519725396153667), 'mean_value': np.float64(4.512531151549349), 'criteria': '0 <= HBA <= 10'}, 'HBD': {'violation_count': np.int64(41), 'violation_rate': np.float64(0.01927869469130578), 'mean_value': np.float64(0.9900456105703672), 'criteria': '0 <= HBD <= 5'}}
  additional: {'TPSA': {'violation_count': np.int64(1944), 'violation_rate': np.float64(0.9140922556072789), 'mean_value': np.float64(65.85911642450746), 'criteria': '0 <= TPSA <= 140'}, 'RotBonds': {'violation_count': np.int64(2615), 'violation_rate': np.float64(1.2296045516527954), 'mean_value': np.float64(4.731104528142192), 'criteria': '0 <= RotBonds <= 10'}}

total_hits: 1000
mean_similarity: 0.659303808489326
max_similarity: 1.0
min_similarity: 0.5844155844155844
std_similarity: 0.07843211835287967
very_high_similarity_count: 3
very_high_similarity_percentage: 0.3
high_similarity_count: 31
high_similarity_percentage: 3.1
medium_similarity_count: 158
medium_similarity_percentage: 15.8
low_similarity_count: 615
low_similarity_percentage: 61.5
very_low_similarity_count: 173
very_low_similarity_percentage: 17.299999999999997
